Young‐Choon Moon

2.9k total citations
23 papers, 661 citations indexed

About

Young‐Choon Moon is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Young‐Choon Moon has authored 23 papers receiving a total of 661 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 7 papers in Organic Chemistry and 4 papers in Oncology. Recurrent topics in Young‐Choon Moon's work include RNA modifications and cancer (4 papers), Biochemical and Molecular Research (3 papers) and RNA and protein synthesis mechanisms (3 papers). Young‐Choon Moon is often cited by papers focused on RNA modifications and cancer (4 papers), Biochemical and Molecular Research (3 papers) and RNA and protein synthesis mechanisms (3 papers). Young‐Choon Moon collaborates with scholars based in United States, India and Canada. Young‐Choon Moon's co-authors include Ramil Baiazitov, Thomas W. Davis, Liangxian Cao, Wu Du, Nadiya Sydorenko, Catherine Frelin, Antonija Kreso, Cherry Leung, Nicholas Pedley and Evelyne Lima‐Fernandes and has published in prestigious journals such as Nature Medicine, PLoS ONE and Cancer Research.

In The Last Decade

Young‐Choon Moon

22 papers receiving 644 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Young‐Choon Moon United States 10 451 235 140 84 48 23 661
Corinne Venot France 12 528 1.2× 404 1.7× 101 0.7× 55 0.7× 36 0.8× 17 751
Naoto Ohi Japan 12 276 0.6× 169 0.7× 100 0.7× 86 1.0× 30 0.6× 19 519
Leanne Cartee United States 14 357 0.8× 226 1.0× 47 0.3× 82 1.0× 99 2.1× 27 646
S Houlbrook United Kingdom 14 744 1.6× 416 1.8× 262 1.9× 74 0.9× 69 1.4× 17 1.0k
Kanda Sangthongpitag Singapore 15 629 1.4× 245 1.0× 45 0.3× 76 0.9× 31 0.6× 25 827
Hima Patel United States 12 383 0.8× 277 1.2× 74 0.5× 53 0.6× 127 2.6× 20 682
Kaushlendra Tripathi United States 17 521 1.2× 223 0.9× 118 0.8× 49 0.6× 50 1.0× 31 718
Mary Luz Uribe Spain 8 259 0.6× 153 0.7× 81 0.6× 45 0.5× 104 2.2× 14 513
Andrea Schweinitz Germany 13 299 0.7× 151 0.6× 230 1.6× 91 1.1× 15 0.3× 23 620

Countries citing papers authored by Young‐Choon Moon

Since Specialization
Citations

This map shows the geographic impact of Young‐Choon Moon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Young‐Choon Moon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Young‐Choon Moon more than expected).

Fields of papers citing papers by Young‐Choon Moon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Young‐Choon Moon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Young‐Choon Moon. The network helps show where Young‐Choon Moon may publish in the future.

Co-authorship network of co-authors of Young‐Choon Moon

This figure shows the co-authorship network connecting the top 25 collaborators of Young‐Choon Moon. A scholar is included among the top collaborators of Young‐Choon Moon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Young‐Choon Moon. Young‐Choon Moon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Morrill, Christie, Westley J. Friesen, Suresh Babu, et al.. (2022). Guanidino quinazolines and pyrimidines promote readthrough of premature termination codons in cells with native nonsense mutations. Bioorganic & Medicinal Chemistry Letters. 76. 128989–128989. 4 indexed citations
2.
Baiazitov, Ramil, Hongyan Qi, Liangxian Cao, et al.. (2022). SAR studies toward discovery of emvododstat (PTC299), a potent dihydroorotate dehydrogenase (DHODH) inhibitor. European Journal of Medicinal Chemistry. 244. 114826–114826. 3 indexed citations
3.
Ma, Jiyuan, Nicole Risher, Valerie Northcutt, et al.. (2021). Ataluren metabolism: Ataluren-O-1β-acyl glucuronide is a stable circulating metabolite in mouse, rat, dog and human. Drug Metabolism and Pharmacokinetics. 38. 100393–100393. 1 indexed citations
5.
Baiazitov, Ramil, Westley J. Friesen, Briana Johnson, et al.. (2020). Chemical modifications of G418 (geneticin): Synthesis of novel readthrough aminoglycosides results in an improved in vitro safety window but no improvements in vivo. Carbohydrate Research. 495. 108058–108058. 6 indexed citations
6.
Kong, Ronald, Jiyuan Ma, Seongwoo Hwang, et al.. (2020). In vitro metabolism, reaction phenotyping, enzyme kinetics, CYP inhibition and induction potential of ataluren. Pharmacology Research & Perspectives. 8(2). e00576–e00576. 10 indexed citations
7.
Friesen, Westley J., Christopher R. Trotta, Jin Zhuo, et al.. (2017). The nucleoside analog clitocine is a potent and efficacious readthrough agent. RNA. 23(4). 567–577. 36 indexed citations
8.
Bakhshinyan, David, Neha Garg, Branavan Manoranjan, et al.. (2017). TRTH-13. BMI1 IS A THERAPEUTIC TARGET IN RECURRENT MEDULLOBLASTOMA. Neuro-Oncology. 19(suppl_4). iv54–iv54. 1 indexed citations
9.
Bansal, Nitu, Monica Bartucci, Shamila Yusuff, et al.. (2016). BMI-1 Targeting Interferes with Patient-Derived Tumor-Initiating Cell Survival and Tumor Growth in Prostate Cancer. Clinical Cancer Research. 22(24). 6176–6191. 49 indexed citations
10.
Cao, Liangxian, Marla Weetall, Hongyan Qi, et al.. (2016). Discovery of Novel Small Molecule Inhibitors of VEGF Expression in Tumor Cells Using a Cell-Based High Throughput Screening Platform. PLoS ONE. 11(12). e0168366–e0168366. 17 indexed citations
11.
Kim, Min Jung, Liangxian Cao, Josephine Sheedy, et al.. (2014). Abstract 5517: PTC596-induced Bmi1 hyper-phosphorylation via Cdk1/2 activation resulting in tumor stem cell depletion. Cancer Research. 74(19_Supplement). 5517–5517. 9 indexed citations
12.
Morrill, Christie, et al.. (2013). Selective Synthesis of 1-Substituted 4-Chloropyrazolo[3,4-d]pyrimidines. Organic Letters. 15(8). 1882–1885. 12 indexed citations
13.
Kreso, Antonija, Peter van Galen, Nicholas Pedley, et al.. (2013). Self-renewal as a therapeutic target in human colorectal cancer. Nature Medicine. 20(1). 29–36. 378 indexed citations
14.
Moon, Young‐Choon, Ramil Baiazitov, Wu Du, et al.. (2013). Chemoselective Reactions of 4,6-Dichloro-2-(methylsulfonyl)pyrimidine and Related Electrophiles with Amines. Synthesis. 45(13). 1764–1784. 17 indexed citations
16.
Friesen, Westley J., Jin Zhuo, Ramil Baiazitov, et al.. (2008). T.P.4.01 Identification and characterization of small molecules for the treatment of Duchenne muscular dystrophy. Neuromuscular Disorders. 18(9-10). 812–812. 1 indexed citations
17.
Perni, Robert B., J. PITLIK, John J. Court, et al.. (2004). Inhibitors of hepatitis C virus NS3·4A protease 2. Warhead SAR and optimization. Bioorganic & Medicinal Chemistry Letters. 14(6). 1441–1446. 41 indexed citations
18.
Thompson, Lorin A., et al.. (1998). Solid-Phase Synthesis of Diverse E- and F-Series Prostaglandins. The Journal of Organic Chemistry. 63(7). 2066–2067. 39 indexed citations
19.
Moon, Young‐Choon, et al.. (1996). Synthesis and Antibacterial Activities of Novel C(7)-Catechol-substituted Cephalosporins (II).. The Journal of Antibiotics. 49(5). 499–501. 3 indexed citations
20.
Moon, Young‐Choon, et al.. (1996). Synthesis and Antibacterial Activities of Novel C(7)-Catechol-substituted Cephalosporins (I).. The Journal of Antibiotics. 49(5). 496–498. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026